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Sarah Ratzel1 and Sara B. Cullinan2GRHL3Mutations Cause Van derWoude Syndrome
Peyrard-Janvid et al., page 23
Van der Woude syndrome (VWS) is the most common
cause of cleft lip and cleft palate. Many affected individ-
uals also have lip pits. Mutations in IRF6 account for
most, but not all, cases of VWS. Supporting the possibility
that mutations in other genes might contribute to VWS,
an alternative locus was identified in a large, VWS-
affected family in which mutations in IRF6 had been
ruled out. In this study, Peyrard-Janvid et al. used exome
sequence from individuals in this family and 44 addi-
tional families to identify several VWS-associated GRHL3
mutations, consistent with an autosomal-recessive mode
of inheritance. However, using a zebrafish model, the
authors verified that five of these alleles were disruptive
to embryo development in a manner consistent with a
dominant-negative mutation. GRHL3 encodes a transcrip-
tion factor, and in zebrafish, the ortholog is important
for periderm development; notably, its expression is regu-
lated by Irf6. Additionally, Grhl3-knockout mice display
palate and oral epithelial defects. By generating Irf6-
Grhl3 double heterozygotes, the authors were able to
investigate epistasis and concluded that Irf6 and Grhl3
function in independent but converging developmental
pathways. Future work will be required for unraveling
how the altered protein products contribute to VWS
disease through both haploinsufficient and dominant-
negative mechanisms.Transmission-Disequilibrium Tests for Rare
Variants
He et al., page 33
As more studies move to using next-generation
sequencing methods to identify rare variants, the sensi-
tivity of population-based study designs to population
substructure and admixture has become a notable
problem. Family-based studies can avoid these pitfalls.
A common test for association in family-based studies is
the transmission-disequilibrium test. However, this test
was not designed to handle rare variants. In their study,
He et al. incorporated methods for identifying rare
variants—Combined Multivariate and Collapsing, the
Weighted Sum Statistic, Burden of Rare Variants, and1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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Ththe Variable Threshold—into the transmission-disequilib-
rium framework. These methods were slightly more
powerful in detecting rare variants than were an equal
number of cases and controls in a population-based study,
but they notably only required phenotyping of the
affected proband rather than of all participating indi-
viduals and avoided the problems caused by population
substructure in population-based studies. Moreover, the
authors applied the tests to autism spectrum disorder
(ASD) trios from the Simons Simplex Collection and
found that rare variants in ABCA7, whose protein product
transports lipids across cell membranes, might contribute
to ASD. Previous work in ASD-affected children identified
linkage regions near this gene; some ASD-affected
children have abnormal lipid metabolic pathways,
supporting a role for ABCA7 mutations in ASD. As trio
sequencing data are collected for a wide variety of disor-
ders, these methods should help to reveal rare variants
that contribute to disease.Systemic Sclerosis on a Chip
Mayes et al., page 47
Systemic sclerosis (also called scleroderma) is a complex
autoimmune disease that displays marked phenotypic
heterogeneity. Previous genome-wide association studies
have pointed to possible roles for immune system loci,
including the major histocompatibility complex, in risk
for this disease, but a significant portion of predicted
heritability remains unmapped. Moreover, without in-
depth knowledge of causal variants, effective treatment
strategies remain elusive. With these goals in mind,
Mayes et al. utilized the Immunochip—a custom geno-
typing array—to perform fine mapping in a combined
data set of nearly 6,000 cases and over 9,000 controls.
The authors were able to narrow the regions of pre-
viously reported associations and identify additional
loci associated with systemic sclerosis, highlighting
the need for further dense genotyping and follow-up
characterization of the identified SNPs. Although the
authors identified some genetic associations that appear
to be unique to systemic sclerosis, their findings also
provide insight into the breadth of shared genetic associ-
ations among autoimmune diseases; such informa-
tion could prove very informative in studies aimed aty of Human Genetics. All rights reserved.
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understanding the biological underpinnings of this
family of diseases.Uncovering an Expansion
Favaro et al., page 120
Exome sequencing has become a very powerful tool in
research of rare diseases, so much so that it can be easy
to forget its limitations. Beyond capturing only coding
(and carefully targeted surrounding) sequences, it is simply
difficult to capture certain areas in the exome. In this issue,
Favaro et al. sought to find the cause of Richieri-Costa-
Pereira syndrome, a rare autosomal disorder characterized
by short stature, mandibular malformations, and limb
defects. Linkage analysis led the authors to suspect that
mutations in EIF4A3might be involved, but whole-exome
sequencing did not reveal any potentially pathogenic var-
iants. Upon further review, however, the authors noted
low coverage of exon 1, most likely owing to high GC con-
tent in the 50 UTR. PCR amplification of the region demon-
strated that affected individuals harbored larger exon 1
alleles than did controls. Indeed, further analysis of the
EIF4A3 50UTR identified a series of expansion alleles, the
longest of which segregated with the disease. Experiments
utilizing zebrafishmorphants confirmed a role for eif4a3 in
craniofacial development. EIF4A3 encodes a core compo-
nent of the exon-junction complex. Although future
studies will be needed for better understanding how
disruption of a general translation-initiation factor causes
this particular disorder, it is interesting to note the recent
findings of other craniofacial disorders, including Nager
syndrome and Treacher Collins syndrome, caused by
mutations in genes encoding proteins involved in RNA
metabolism.2 The American Journal of Human Genetics 94, 1–2, January 2, 2014Disparate Phenotypes from TBC1D24 Mutations—
Epilepsy or Deafness
Rehman et al., page 144
Deafness can be caused by mutations in many widely
expressed genes with a multitude of associated functions.
This underlying feature of deafness might also contribute
to the heterogeneous presentation of the disorder. In this
report, Rehman et al. used both linkage analysis to define
a deafness locus (DFNB86) and exome sequencing to iden-
tify mutations in TBC1D24 as a cause of deafness.
TBC1D24 is broadly expressed across many types of
human tissues. Immunolocalization of TBC1D24 in the
mouse inner ear showed strong protein accumulation in
spiral ganglion cells. Interestingly, previous studies have
identified recessive mutations in TBC1D24 as a cause of
infantile myoclonic epilepsy, but hearing loss was not
examined in these individuals. To determine whether
DFNB86-affected individuals might also have a history of
seizures, the authors examined clinical data for both deaf
and normal-hearing individuals. Of the deaf individuals
with TBC1D24 mutations, only one had a history of
seizures: during childhood, she had one seizure associated
with a fever. Additionally, two unaffected individuals
(without TBC1D24 mutations) from this family also had
a potential history of seizures: one individual had a few sei-
zures per month, and one had EEG activity consistent with
seizure activity, but no reported seizures. In a second fam-
ily with available clinical data, there was no history of sei-
zures, suggesting that the previously reported data might
be consistent with the frequency of seizures in the normal
population. It will be intriguing to determine whether the
phenotypes are truly independent in a larger sample and
how mutations in the same gene, and even within the
same domain, might lead to two distinct phenotypes.
